Tag: abeona therapeutics

April 30, 2019

Abeona Therapeutics Presents New Preclinical Data of ABO-401

Abeona Therapeutics announced the presentation of new preclinical data on its candidate ABO-401.
December 7, 2018

Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs

Abeona Therapeutics (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
April 23, 2018

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
April 20, 2018

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
March 15, 2018

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...
February 15, 2018

Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks?

INN is taking a look at what other companies have received FDA approval for gene therapy drugs and how the...
February 13, 2018

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program

Abeona Therapeutics (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...